通过提格兰醇提格酸的免疫性瘤溶解
Jonathan G Pol1,2, Manuela Lizarralde-Guerrero1,2,3, Guido Kroemer1,2,4
1Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université de Paris Cité, Sorbonne Université, Paris, France.
Oncoimmunology
|May 30, 2024
概括
提格兰醇提格酸,一种热致死诱导剂,在癌症中触发免疫细胞死亡. 它还增强了免疫检查点抑制剂如CTLA-4和PD-1在注射到瘤时的有效性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 提格兰醇提格酸是一种正在研究中的瘤性小分子.
- 热是癌症细胞死亡的一个关键机制.
研究的目的:
- 为了研究tgilanol的免疫细胞死亡 (ICD) 特性.
- 评估tigilanol tiglate对免疫检查点抑制剂敏感化瘤的潜力.
主要方法:
- 提格兰醇提格酸因其诱导ICD特征的能力而被研究.
- 皮下癌症模型接受了提格兰醇提格兰酸的治疗,随后接受了免疫检查点抑制剂.
主要成果:
- 提格兰醇提格酸证明了诱导免疫细胞死亡的关键特征的能力.
- 内提格兰醇提格兰酸的给药使瘤对CTLA-4和PD-1阻断产生敏感性.
结论:
- 提格兰醇提格酸表明作为一种抗瘤剂的承诺,可以增强抗瘤免疫力.
- 与提格兰醇提格酸和免疫检查点抑制剂的联合治疗可能代表了一种新的癌症治疗策略.
相关概念视频
Tumor Immunotherapy
514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514
Cytotoxic T Cells-mediated Immune Response
891
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
891
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


